The market is expected to exhibit high growth in developed economies such as the U.S. and Europe over the forecast period. The rapid increase in the number of patients suffering from depression is expected to be one of the main driving forces for the estimated growth, which can be attributed to elevating stress levels, unhealthy lifestyle, and social imbalances. In the U.S. and Europe, various regulations pertaining to drug approval and patents, as well as commercial issues, such as restriction on the sale of antidepressants without prescription are the major restraints which are expected to negatively impact market growth. Rise in various medical disorders due to increase in stress levels and unhealthy lifestyle in Asia Pacific and the Middle East is expected to lead to market expansion.
The acceptability of various drugs is expected to increase due to growing public awareness regarding depression and associated disorders. This is expected to result in increasing drug penetration.
Depression drugs, as the name suggests, are primarily used for the treatment of depression, and also known as antidepressants. These drugs are also used in the treatment of a wide range of medical conditions such as anxiety disorders, neuropathic pain, eating disorders, chronic pain and obsessive compulsive disorder. The depression drug market includes a wide range of drugs, and can be segmented on the basis of key product types, which are Tricyclic antidepressants (TCAs), Serotonin norepinephrine reuptake inhibitors (SNRIs), Selective serotonin reuptake inhibitors (SSRIs), Monoamine oxidase inhibitors (MAOIs), and atypical antidepressants.
Some of the key vendors operating in this market include Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Lundbeck, Forest Laboratories and others.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Rest of the World
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
Browse Upcoming Reports @:http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
90 State Street,
Albany NY - 12207